4519中外製薬

Print Friendly, PDF & Email

ロシュ傘下で成長続ける異色の医薬品大手。抗体・バイオで先行、抗がん剤、骨・関節領域に強い

会社サイト   株価   適時開示   大量保有報告書   有価証券報告書

開示年月日決算期種別連個実予売上収益営業利益税前利益当期利益配当1Q2Q3Q
2006/02/092005/12年度327,15579,16882,09153,632340120
2006/02/092006/06中間147,500 24,10013,90000未定0
2006/07/312006/06中間152,62427,41229,84018,79300120
2006/02/092006/12年度313,000 54,40031,800未定0未定0
2007/02/072006/12年度326,10958,34760,92238,417300120
2007/02/072007/06中間154,50021,00021,00012,00000未定0
2007/07/312007/06中間170,87735,77936,75021,10900150
2007/02/072007/12年度332,00052,50052,50031,000未定0未定0
2008/01/302007/12年度344,80866,70267,68740,060300150
2008/01/302008/06中間148,20012,50012,7007,10000未定0
2008/07/312008/06中間145,87723,12224,31918,87200150
2008/01/302008/12年度327,00031,50031,20017,000未定0未定0
2009/02/042008/12年度326,93751,56357,26539,264340150
2009/04/242009/031Q94,69017,53122,79713,7670000
2009/02/042009/062Q199,50035,00035,50022,00000170
2009/07/232009/062Q191,69137,17543,45426,30600170
2009/10/272009/093Q309,71358,78466,04340,88900170
2009/02/042009/12年度400,00063,00063,50040,000340170
2009/10/072009/12年度420,00067,00074,00046,000340170
2010/02/032009/12年度428,94782,61290,93556,634400170
2010/04/232010/031Q87,08411,07812,0547,8520000
2010/02/032010/062Q189,10026,50027,00016,70000170
2010/07/222010/062Q182,37927,56226,15816,37600170
2010/10/222010/093Q276,07645,12944,25828,05300170
2010/02/032010/12年度418,50070,00070,50044,000340170
2010/10/222010/12年度395,80070,00068,70043,000340170
2011/02/022010/12年度379,50966,23865,08841,433400170
2011/04/212011/031Q85,72415,56416,6854,9890000
2011/02/022011/062Q190,00034,00034,50017,00000200
2011/04/212011/062Q190,00034,00034,50012,50000200
2011/07/212011/062Q181,93835,19136,18217,08700200
2011/10/212011/093Q276,01850,01351,05927,12900200
2011/02/022011/12年度403,00075,00075,50042,500400200
2011/04/212011/12年度403,00075,00075,50037,000400200
2011/07/212011/12年度395,20072,00073,10037,000400200
2012/02/012011/12年度373,51662,43063,58535,234400200
2012/04/242012/031Q90,25616,61516,3049,3420000
2013/04/252012/031QIFRS90,28717,85717,47210,7090000
2012/02/012012/062Q195,50036,50037,00022,00000200
2012/07/262012/062Q185,26334,32834,34720,88900200
2013/07/252012/062QIFRS185,45236,41435,15521,63000200
2012/10/232012/093Q275,40848,23048,07429,84100200
2013/10/252012/093QIFRS275,59150,84849,51530,73800200
2012/02/012012/12年度418,50080,00080,50049,000400200
2013/01/302012/12年度391,22076,41375,40648,205400200
2013/01/302012/12年度IFRS386,55274,66372,67846,052400200
2013/04/252013/031QIFRS90,41614,66313,6608,8970000
2013/01/302013/062QIFRS非開示   00220
2013/07/252013/062QIFRS201,01638,12036,94624,74800220
2013/10/252013/093QIFRS306,56358,16056,72238,16400220
2013/01/302013/12年度IFRS416,00077,500非開示 450220
2014/01/302013/12年度IFRS423,65278,73876,94450,895450220
2014/04/242014/031QIFRS124,04531,08931,26318,7760000
2014/01/302014/062QIFRS非開示   00220
2014/07/242014/062QIFRS222,02243,11743,43528,89700220
2014/10/242014/093QIFRS333,42659,13459,42039,73000220
2014/01/302014/12年度IFRS451,00071,000非開示 450220
2015/01/282014/12年度IFRS461,10975,85976,16450,980480220
2015/04/222015/031QIFRS117,08320,75021,17414,5820000
2015/01/282015/062QIFRS非開示   00260
2015/07/232015/062QIFRS240,17843,21043,85230,13700260
2015/10/222015/093QIFRS367,77267,05967,39047,64700260
2015/01/282015/12年度IFRS486,50077,321非開示  520260
2016/01/282015/12年度IFRS498,83986,78487,27661,125580260
2016/04/222016/031QIFRS119,89320,05320,13414,5000000
2016/01/282016/062QIFRS非開示   00260
2016/07/212016/062QIFRS247,53143,51343,79831,54900260
2016/10/252016/093QIFRS361,51758,63559,05943,08400260
2016/01/282016/12年度IFRS495,00071,000非開示 520260
2017/02/012016/12年度491,78076,88474,44853,592520260
2017/04/252017/031QIFRS125,46726,34524,95518,5000000
2017/02/012017/062Q非開示   00290
2017/07/272017/062QIFRS252,77447,10146,40736,10000290
2017/10/252017/093QIFRS387,64576,22374,85357,19600290
2017/02/012017/12年度520,50092,000非開示 580290
2018/02/012017/12年度IFRS534,19998,93497,03172,713620290
2018/04/242018/031QIFRS147,42738,36237,65327,8880000
2018/02/012018/062QIFRS非開示   00310
2018/07/262018/062QIFRS285,12366,56964,99648,67200310
2018/10/242018/093QIFRS426,44097,91295,63270,34000310
2018/02/012018/12年度IFRS541,500108,000非開示 620310
2019/01/312018/12年度IFRS579,787124,323121,44992,488860310
2019/04/242019/031QIFRS154,28846,09445,42135,0310000
2019/01/312019/062QIFRS非開示00480
2019/07/252019/062QIFRS320,28595,05293,78069,25400480
2019/10/242019/093QIFRS508,851160,878158,577117,39500480
2019/01/312019/12年度IFRS592,500143,000非開示960480
2019/10/242019/12年度IFRS680,000218,000非開示960480
2020/01/302019/12年度IFRS686,184210,597207,893157,5601400480
2020/04/232020/031QIFRS179,42472,41171,21451,5330000
2020/07/272020/062QIFRS368,120140,629139,565102,29300750
2020/01/302020/062QIFRS非開示00750
2020/01/302020/12年度IFRS740,000275,000201,0001000750

2013/12期以降の営業利益の予測値は会社の管理指標のCore営業利益を開示。
2020/7に株式分割(1→3)

中外薬